Nuvectis Pharma, Inc. (NVCT)
23.87
+0.31
(+1.32%)
USD |
NASDAQ |
Aug 24, 16:00
23.86
-0.01
(-0.04%)
After-Hours: 20:00
Nuvectis Pharma Net Income (Quarterly) : -7.02M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.02M |
| March 31, 2026 | -6.05M |
| December 31, 2025 | -7.314M |
| September 30, 2025 | -9.891M |
| June 30, 2025 | -6.334M |
| March 31, 2025 | -5.332M |
| December 31, 2024 | -6.248M |
| September 30, 2024 | -4.153M |
| June 30, 2024 | -4.428M |
| March 31, 2024 | -4.171M |
| December 31, 2023 | -6.622M |
| Date | Value |
|---|---|
| September 30, 2023 | -5.881M |
| June 30, 2023 | -5.708M |
| March 31, 2023 | -4.049M |
| December 31, 2022 | -6.696M |
| September 30, 2022 | -5.877M |
| June 30, 2022 | -3.569M |
| March 31, 2022 | -2.943M |
| December 31, 2021 | -2.261M |
| September 30, 2021 | -4.668M |
| June 30, 2021 | -5.938M |
| March 31, 2021 | -0.023M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Decoy Therapeutics, Inc. | -2.374M |
| Unicycive Therapeutics, Inc. | -1.722M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.02M |
| EPS Diluted (Quarterly) | -0.299 |
| Enterprise Value | 615.04M |
| Earnings Yield | -5.35% |
| Normalized Earnings Yield | -5.352 |